Production & Manufacturing
Manufacturing

Manufacturing News

View news from other Pharmaceutical sectors:
1-15 of 2297 results
Sanofi to buy hemophilia specialist Bioverativ for $11.6bn
By PBR Staff Writer
French drugmaker Sanofi has agreed to acquire US-based biotechnology firm Bioverativ for about $11.6bn.
Production & Manufacturing > Manufacturing > News
Almac to further expand Ireland campus with £30m investment
By PBR Staff Writer
Northern Ireland-based pharmaceutical firm Almac is investing £30m to further expand its European campus in Dundalk, Ireland to cope up with its existing and future client requirements in the European Union market.
Production & Manufacturing > Manufacturing > News
CGT Catapult to support CombiGene’s gene therapy for epilepsy
By PBR Staff Writer
Cell and Gene Therapy (CGT) Catapult and Sweden-based CombiGene have signed an agreement to develop manufacturing process for novel gene therapy to treat epilepsy.
Production & Manufacturing > Manufacturing > News
Amryt signs deal for Lojuxta drug distribution in Switzerland
Amryt has signed an exclusive distribution agreement with GryNumber Health (GryNumber) for the distribution of Lojuxta (lomitapide) in Central and Eastern Europe (CEE).
Production & Manufacturing > Manufacturing > News
Regeneron forms consortium to accelerate sequencing of UK Biobank data
A new partnership between Regeneron Pharmaceuticals and five other drug manufacturers intends to accelerate the generation of genetic exome sequence data from the 500,000 participants of the UK Biobank.
Production & Manufacturing > Manufacturing > News
Cardiff University researchers develop new tool to assess racemisation risk in drugs
Researchers at Cardiff University in the UK have developed a new method to test the likelihood of a drug turning into a potentially harmful version of itself when it enters the body.
Production & Manufacturing > Manufacturing > News
Allergan to cut over 1,000 jobs to reduce costs
By PBR Staff Writer
Irish drug maker Allergan plans to lay off more than 1,000 jobs globally as part of a cost cutting and restructuring program.
Production & Manufacturing > Manufacturing > News
ANI Pharmaceuticals buys four AstraZeneca NDAs
By PBR Staff Writer
ANI Pharmaceuticals has acquired the new drug applications (NDAs) and US marketing rights for AstraZeneca’s Atacand, Atacand HCT, Arimidex, and Casodex for $46.5m.
Production & Manufacturing > Manufacturing > News
Impax to sell Taiwan manufacturing facility to Bora Pharmaceuticals
Impax Laboratories has agreed to divest its manufacturing facility in Taiwan (Impax Taiwan) to Bora Pharmaceuticals.
Production & Manufacturing > Manufacturing > News
FDA proposes risk-based enforcement approach to homeopathic drugs
By PBR Staff Writer
The US Food and Drug Administration (FDA) is proposing new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs.
Production & Manufacturing > Manufacturing > News
CHMP recommends approval of darvadstrocel to treat complex perianal fistulas in Crohn’s disease
Takeda Pharmaceutical and TiGenix reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel).
Production & Manufacturing > Manufacturing > News
FDA approves Pfizer’s Xeljanz and Xeljanz XR to treat active psoriatic arthritis
The US Food and Drug Administration (FDA) has approved Pfizer’s Xeljanz 5 mg twice daily (BID) and Xeljanz XR (tofacitinib) extended release 11 mg once daily (QD) for the treatment of adult patients with active psoriatic arthritis (PsA) who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
Production & Manufacturing > Manufacturing > News
Drugmaker Teva to cut 14,000 jobs globally
By PBR Staff Writer
Teva Pharmaceutical Industries said it will lay off 14,000 jobs globally as part of a two-year restructuring plan, aimed at boosting its business and financial performance.
Production & Manufacturing > Manufacturing > News
Flexion Therapeutics to acquire novel and non-opioid asset for osteoarthritis of knee
Flexion Therapeutics has entered into a definitive agreement with GeneQuine Biotherapeutics GmbH to acquire the global rights to GQ-203.
Production & Manufacturing > Manufacturing > News
Pfizer's biosimilar of J&J's Remicade secures FDA approval
By PBR Staff Writer
Pfizer’s IXIFI (PF-06438179, infliximab-qbtx), a biosimilar to Johnson & Johnson’s rheumatoid arthritis drug Remicade (infliximab), has been approved by the US Food and Drug Administration (FDA) for all indications of the reference product.
Production & Manufacturing > Manufacturing > News
1-15 of 2297 results